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This paper presents a biosensor implementation for the detection of protein molecules using specific
antibodies. Affinity sensors allow the detection and quantification of target molecules in complex
mixtures by affinity-based interactions. Immobilized antibody molecules are the probes that bind to
specific protein molecules (targets) in biological fluids. In this study, inter-digitated electrodes in the
form of capacitance on glass slide were designed, fabricated and used to measure the changes
in the dielectric properties of the inter-digitated capacitances. Our results in this study present that
with a careful design of micro-interdigitated capacitors, a wider dynamic range and higher sensitivity
can be achieved for the detection and quantification of C-Reeactive Protein.
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1. INTRODUCTION
Biosensors are fast, direct, and with ability to perform
label-free measurements are attractive for different appli-
cations. The affinity based interactions/sensing approaches
by name mean use of specific antigen/antibody, allow the
detection and quantification of target molecules in complex
mixtures. So, with this approach we can detect the specific
proteins without labeling (Label-free) them. Immobilized
antibody molecules are the probes that bind to specific pro-
tein molecules (targets) in biological fluids. Inter-digitated
electrodes in the form of capacitance on glass slide can
be used to measure the changes in the dielectric prop-
erties of the inter-digitated capacitances upon antigen
binding.1
Besides the inexpensive production and low sample con-
sumption, main advantages of inter-digitated, capacitive
immuno-sensors are (1) the label-free detection mecha-
nisms and (2) the fast and reliable measurements. Unlike
other detection mechanisms used to quantify protein con-
centrations, capacitive method does not need labeling
of samples prior to analysis. Upon binding of protein
molecules to the immobilized antibody molecules on the
surface of electrodes, dielectric properties between the
inter-digitated electrodes changes and measurement can
be taken immediately after hybridization.23 The detection
mechanism of these sensors is based on the change in
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the dielectric constant of the inter-digitated capacitance.
This change arises, at the simplest form, from the equation
C = oA/d, where C is the capacitance between the
inter-digitated electrodes,  is the dielectric constant of
the medium between the plates, o is the dielectric con-
stant of free space, A is the area of the plates and d is
the distance. When a change in dielectric constant occurs,
a counter change occurs in capacitance value in between
the electrodes.1
This change in the dielectric constant, hence in the
capacitance, is correlated to the bound antigen molecules
to the capture antibodies on the surface, between the elec-
trodes. The dielectric constant of the antibodies changes
the dielectric constant between the electrodes/fingers and
this result in a change in capacitance. Inter-digitated elec-
trode arrays are used in order to increase the active area
for higher sensitivity to binding events. Atomic Force
Microscopy (AFM) and electrochemical methods are used
to measure this change, but impedance analysis gives faster
results.4
Biosensor applications for various human serum pro-
teins are available. C-reactive protein (CRP) is one of the
inflammation markers in human serum.5 Recent articles
have shown significance of inflammatory markers in early
detection of cardiovascular disease.67 CRP is emerging
as a new marker for acute phase inflammation and has
showed a lot of potential for earlier detection of cardio-
vascular diseases.89
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2. STRUCTURAL MODELLING AND
EXPERIMENTAL
2.1. Structural Design and Modeling
Multi-finger types of capacitors are widely used in
microstrip technology. The capacitor itself is defined
between the two ports as shown in Figure 1(a). The inter-
digital capacitor couples the two coplanar waveguides
by the electromagnetic field in its region. In a nutshell,
the variation of medium between the fingers of inter-digital
capacitor, will lead to variation in effective dielectric con-
stant of the area. This directly changes the total capaci-
tance of inter-digital capacitance. Figure 1(b) depicts the
equivalent circuit of the inter-digital capacitor. Magnetic
coupling between the fingers, a transformer with the self-
inductances L1 and L2 and the mutual inductance M is
used. In order to decrease these inductances, long fingers
are not being used. The ohmic losses that occur due to the
current flow through the fingers can be descried by two fre-
quency dependent resistors Rf1 and Rf2. There resistances
must be decreased for instance using thicker metal layer
to get rid of losses. The capacitances Cp1 and Cp2 repre-
sent the stray fields from the fingers to the ground plane.
Therefore in our design the distance between the ground
layer and inter-digital electrodes is increased.
The simulation of this type of structures at high fre-
quencies is not easy and electromagnetic simulators like
MOMENTUM/HFSS should be used for high accuracy.
In this work, modeling and simulation of inter-digital
capacitors are performed using ADS (Advance Design
System) MOMENTUM® and HFSS® tools.
The structure/model, shown in Figure 1, is simulated
in the frequency range of 1 GHz to 5 GHz. One of the
ports is grounded during the simulations. The optimum fre-
quency range, selected the one having a maximum capac-
itance change, is between 2–3 GHz. This frequency range
is also known as industrial, scientific and medical (ISM)
radio bands, originally reserved internationally for non-
commercial use of RF electromagnetic fields for industrial,
scientific and medical purposes. Figure 2 presents the
fabricated/realized inter-digital capacitor structure.
(a) (b)
Fig. 1. Two-port, inter-digitated capacitors (a) and its electrical
model (b).
Fig. 2. Nickel IDC with SU8 wells.
The S-parameters of the structure in Figure 1 are
extracted from the simulation results and actual values
are measured using a Network Analyzer. The resulting
capacitance values from simulations and measurements for
the mentioned frequency range are presented in Figure 3,
respectively. The Figure 3 envisages that the capacitance
value by simulation at 2.354 GHz is found as 1.829 pF,
Figure 3(a) that is very close to measured value of 1.8 pF,
Figure 3(b).
2.2. Sensor Fabrication
The fabrication flow for the structure shown in Figure 2 is
presented in Figure 4. Very thin tungsten layer of 30 nm
is sputter deposited on the glass microscope slide, which
is used to improve the adhesion of gold on substrate.
Then 300 nm of gold is deposited using sputter deposi-
tion, as seen in step (A). Following this step, the gold
layer is patterned by wet etching with the mask seen in the
step (B). I2/KI/H2O solution is used to etch gold layer and
30% hydrogen peroxide (H2O2) is used to etch the under-
lying tungsten layer. After that, an oxide layer of 50 nm
is deposited on the electrodes, step (C), and the top of the
contact pads are opened using HF solution, step (D). The
oxide layer is deposited to improve the coating of epoxy
silane layer, which will be used to immobilize antibodies
and to insulate the electrodes. Length of each electrode is
750 m and width is 25 m. The distance between two
electrodes is 25 m. To ease the process of fabrication
gold metal is replaced with Nickel. Image Reversal Tech-
nique with AZ 5214 E is used to Pattern Nickel Metal,
step (D) in the above process is omitted as Nickel read-
ily forms oxide. A 40 m deep SU8 wells were patterned
over the inter-digitated structure for easing the antibody
immobilization on the sensor structure. Figure 2 shows the
fabricated Nickel IDC with SU8 wells.
2.3. Materials and Reagents
Monoclonal antibody and purified antigens for C-Reactive
Protein were purchased from Fitzgerald Industries Inter-
national (Concord, MA, USA). Alexa-488 conjugated
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(a)
(b)
Fig. 3. Simulated (a) and measured (b) values of the inter-digital
capacitors.
rabbit anti-mouse antibody was purchased from Invitro-
gen (Carlsbad, CA, USA). (3-glycidoxypropyl)-trimethoxy
silane (GPTS), BSA, PBS and Tween 20 were purchased
from Sigma (USA). Fluorescent scanning was carried out
using an ArrayWoRx(R) Biochip Reader (Applied Preci-
sion, Marlborough, UK) and analyzed by using accom-
panying software. PBS-T (1X PBS, 0.5% Tween 20) and
Diluent buffer (2% BSA in BPS-T) were used for all wash-
ing and dilution steps, otherwise noted.
2.4. Surface Activation and Antibody Immobilization
2% of (3-glycidoxypropyl)-trimethoxy silane (GPTS) solu-
tion was used to coat SiO2 surface. After one hour silaniza-
tion reaction, sensors were washed several times with
ethanol and dried using centrifuge. 2 l of C-reactive pro-
tein antigen at 0.5 mg/ml concentration was added onto
surface and incubated for two hours at room temperature.
After immobilization step, biosensor surface was blocked
using 2% BSA for nonspecific binding of antigen. After
Fig. 4. Inter-digital capacitor fabrication/process.
several times washing with PBS-T, sensors were stored at
4 C until use.
2.5. Measurements
Purified antigens were diluted in diluent buffer and incu-
bated with sensors for one hour. After several washing
steps, sensors were dried using centrifuge. Karl-Suss PM-5
RF Probe Station and Agilent-8720ES S-Parameter Net-
work Analyzer were used for all capacitance measure-
ments. Network Analyzer were calibrated using SOLT
(short-open-load-through) method and S-Parameter data of
the capacitor were measured. Finally, capacitance values
(C) were extracted from the measurements at certain fre-
quencies (f ). Only 1 to 5 GHz range was scanned.
3. RESULTS AND DISCUSSION
3.1. Antibody Immobilization
Immobilization of C-reactive protein specific antibodies
onto epoxy coated biosensor surface was checked using
Alexa-488 labeled antibodies. Fluorescent conjugated anti-
mouse antibodies were hybridized with capture antibodies
on the surface. Fluorescent scanner was used to scan the
sensors fabricated on the microscope slide by following
the method mentioned in experimental section.
Fluorescent image can be seen in Figure 5. We have
found that 0.5 mg/ml antibody concentration is optimum
for immobilization procedure. 2% BSA blocking is shown
to be efficient, as seen in Figure 5, where no fluorescent
signal was detected when only BSA blocked sensor was
incubated with fluorophore labeled anti-mouse antibody.
Sensor Letters 6, 1–5, 2008 3
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Fig. 5. Antibody immobilization confirmed by hybridization with
Alexa-488 labeled anti-mouse antibodies.
3.2. Antigen Detection
C-reactive protein antigen were diluted to different con-
centration using diluent buffer and hybridized with sen-
sor for 1 hour. After several washing steps and drying,
capacitance measurements were carried out by following
the protocol in experimental section. Capacitance values
were extracted from measurements for each different anti-
gen concentration. We have observed an inductive behav-
ior after 2.7 GHz frequency, therefore capacitance values
for frequencies higher than 2.7 GHz were not considered.
Capacitance change versus frequency graph can be seen in
Figure 6.
Concentrations versus capacitance changes were cal-
culated for some of the frequency points, as shown in
Figure 7(a) and changes in capacitance at various stages
blank(0), epoxy coated(1), antibody coated(2), blocked(3),
and antigen incubation(4), were presented in Figures 7(b)
and (c). These frequencies can be used for further exper-
iments. We have found that concentration versus capac-
itance change at 2.62 GHz is linear over 100 ng/ml to
800 ng/ml antigen concentration range, with R2 equals to
0.97, as presented in Figure 8.
We have showed that capacitance change upon binding
of antigen to the immobilized capture antibodies on the
surface is correlated to the antigen concentration in the
buffer. Although the detection range is not low comparing
Fig. 6. Frequency versus capacitance change for different antigen
concentration.
(a)
(b)
(c)
Fig. 7. Concentration versus capacitance change at different frequen-
cies (1–25 means Capacitance measured after epoxy coating that will be
incubated with 25 ng/ml antigens).
Fig. 8. Capacitance change versus antigen concentration at 2.62 GHz.
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to other available systems, optimization of capacitor
geometries can further enhance the sensor detection limits.
4. CONCLUSIONS
In this study, we have analyzed the reliability of inter-
digitated electrodes for biosensor applications. Biosensors
based on antibody–antigen interactions can be used for
quantification of biomarkers in human serum. High sen-
sitivity and improved detection range can be obtained
through optimization of topology/geometry of capacitors.
Furthermore, integration with microfluidics systems for
sample delivery can further improve the overall stabil-
ity and reproducibility of inter-digitated electrodes based
immuno-biosensor.
Although we have used C-reactive protein as a model
system, this antibody based, label-free detection system
can be applied to other areas, such as, microbiological
detection, DNA detection or biomarker detection.
Inter-digitated electrodes can be further designed in
an array format and integrated into other Micro-Electro-
Mechanical devices/systems for further improvements of
performance, cost, reliability, etc. Using arrays of capac-
itors may allow us to quantify more than one marker at
a time and enhance the diagnostic power of biosensor.
Besides high throughput capability of these biosensors,
further integration of other electronics parts can improve
the signal-to-noise ratio as well.
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